113984-79-5

Upstream product

• 18162-48-6 tert-butyldimethylsilyl chloride 
• 459-56-3 4-fluorobenzylic alcohol 
• 113984-77-3 1-(tert-butyldimethylsiloxymethyl)-4-fluoro-3-hydroxybenzene 
• 113984-76-2 1-(tert-butyldimethylsilyloxymethyl)-4-fluorobenzene 
• 121-43-7 Trimethyl borate 

Downstream Products

• 113984-81-9 3,5-bis(tert-butyldimethylsilyloxy)-1-(tert-butyldimethylsilyloxymethyl)-4-fluorobenzene 
• 909854-04-2 tert-butyl-(3,5-diethoxy-4-fluoro-benzyloxy)-dimethyl-silane 
• 909854-03-1 3,5-Diethoxy-4-fluoro-benzaldehyde 
• 909854-05-3 (3,5-diethoxy-4-fluoro-phenyl)-methanol 
• 1272527-98-6 4-(4-fluoro-3,5-diisopropoxybenzamido)benzoic acid 
• 1272528-79-6 methyl 4-(4-fluoro-3,5-diisopropoxybenzamido)benzoate 
• 1272528-78-5 4-fluoro-3,5-diisopropoxybenzoic acid 
• 1272528-77-4 (4-fluoro-3,5-diisopropoxyphenyl)methanol 
• 1272528-76-3 tert-butyl(4-fluoro-3,5-diisopropoxybenzyloxy)dimethylsilane 
• 132303-48-1 (5,7-Bis-benzyloxy-6-fluoro-1H-indol-3-ylmethyl)-trimethyl-ammonium; iodide 
• 132303-38-9 5,7-Bis-benzyloxy-6-fluoro-1H-indole-2-carboxylic acid methyl ester 
• 132303-51-6 (5,7-Bis-benzyloxy-6-fluoro-1H-indol-3-yl)-acetonitrile 
• 132303-47-0 (5,7-Bis-benzyloxy-6-fluoro-1H-indol-3-ylmethyl)-dimethyl-amine 
• 132303-54-9 2-(5,7-Bis-benzyloxy-6-fluoro-1H-indol-3-yl)-ethylamine 

Relevant academic research and scientific papers

Therapeutic Aryl-Amido-Aryl Compounds and Their Use

The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-amido-aryl compounds of the following formula (for convenience, collectively referred to herein as “AAA compounds”), which, inter alia, a

THERAPEUTIC ARYL-AM I DO-ARYL COMPOUNDS AND THEIR USE

The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-amido-aryl compounds of the following formula (for convenience, collectively referred to herein as "AAA compounds"), which, inter alia, a

4,4-DISUBSTITUTED PIPERIDINE DERIVATIVES

This invention relates to 4,4-disubstituted piperidine derivatives of the formula (I) wherein A and R1 to R5 are as defined in the specification, and pharmaceutically acceptable salts thereof. The invention further relates to pharmac

PHENYL, PYRIDINE, QUINOLINE, ISOQUINOLINE, NAPHTHYRIDINE AND PYRAZINE DERIVATIVES

This invention is concerned with compounds of the formulaand pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are associated with the modulation of SST receptors subtype 5.

PYRIDINE, QUINOLINE AND PYRIMIDINE DERIVATIVES

This invention is concerned with compounds of the formula wherein A, R1 to R5 are as defined in the specification and G is a pyridine, quinoline or pyrimidine group as defined in the specification, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are associated with the modulation of SST receptors subtype 5.

tert-BUTYLDIMETHYLSILYL ETHERS OF PHENOLS: THEIR ONE-STEP CONVERSION TO BENZYL OR METHYL ETHERS AND UTILITY IN REGIOSELECTIVE ortho LITHIATION

A new method for the one-step conversion of tert-butyldimethylsilyl ethers of phenols to benzyl or methyl ethers and the blocking effect of the tert-butyldimethylsilyloxy group in regioselective ortho lithiation are described.